Literature DB >> 28089769

Nuclear translocation of STAT3 and NF-κB are independent of each other but NF-κB supports expression and activation of STAT3.

Antons Martincuks1, Katarzyna Andryka2, Andrea Küster1, Hildegard Schmitz-Van de Leur1, Michal Komorowski2, Gerhard Müller-Newen3.   

Abstract

NF-κB and STAT3 are essential transcription factors in immunity and act at the interface of the transition from chronic inflammation to cancer. Different functional crosstalks between NF-κB and STAT3 have been recently described arguing for a direct interaction of both proteins. During a systematic analysis of NF-κB/STAT3 crosstalk we observed that appearance of the subcellular distribution of NF-κB and STAT3 in immunofluorescence heavily depends on the fixation procedure. Therefore, we established an optimized fixation protocol for the reliable simultaneous analysis of the subcellular distributions of both transcription factors. Using this protocol we found that cytokine-induced nuclear accumulation of NF-κB or STAT3 did not alter the subcellular distribution of the other transcription factor. Both knockout and overexpression of STAT3 does not have any major effect on canonical TNFα-NF-κB signalling in MEF or HeLa cells. Similarly, knockout of p65 did not alter nuclear accumulation of STAT3 in response to IL-6. However, p65 expression correlates with elevated total cellular levels of STAT3 and STAT1 and supports activation of these transcription factors. Our findings in MEF cells argue against a direct physical interaction of free cellular NF-κB and STAT3 but point to more intricate functional interactions.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Crosstalk; NF-κB; Nuclear translocation; STAT3; Signal transduction

Mesh:

Substances:

Year:  2017        PMID: 28089769     DOI: 10.1016/j.cellsig.2017.01.006

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  Uric Acid Neuroprotection Associated to IL-6/STAT3 Signaling Pathway Activation in Rat Ischemic Stroke.

Authors:  Alicia Aliena-Valero; Sergio Rius-Pérez; Júlia Baixauli-Martín; Germán Torregrosa; Ángel Chamorro; Salvador Pérez; Juan B Salom
Journal:  Mol Neurobiol       Date:  2020-09-22       Impact factor: 5.590

2.  Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading.

Authors:  Ido Goldstein; Ville Paakinaho; Songjoon Baek; Myong-Hee Sung; Gordon L Hager
Journal:  Nat Commun       Date:  2017-11-29       Impact factor: 14.919

Review 3.  STAT3 and STAT5 Activation in Solid Cancers.

Authors:  Sebastian Igelmann; Heidi A Neubauer; Gerardo Ferbeyre
Journal:  Cancers (Basel)       Date:  2019-09-25       Impact factor: 6.639

4.  CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3.

Authors:  Susana P Egusquiaguirre; Suhu Liu; Isidora Tošić; Kevin Jiang; Sarah R Walker; Maria Nicolais; Tzuen Yih Saw; Michael Xiang; Katarina Bartel; Erik A Nelson; David A Frank
Journal:  Neoplasia       Date:  2019-11-22       Impact factor: 5.715

Review 5.  Nucleocytoplasmic Shuttling of STATs. A Target for Intervention?

Authors:  Sabrina Ernst; Gerhard Müller-Newen
Journal:  Cancers (Basel)       Date:  2019-11-19       Impact factor: 6.639

6.  Dynamic chromatin accessibility landscape changes following interleukin-1 stimulation.

Authors:  Matt J Barter; Kathleen Cheung; Julia Falk; Andreas C Panagiotopoulos; Caitlin Cosimini; Siobhan O'Brien; Karina Teja-Putri; Graham Neill; David J Deehan; David A Young
Journal:  Epigenetics       Date:  2020-08-02       Impact factor: 4.528

Review 7.  Insulin/IGF-1 signaling promotes immunosuppression via the STAT3 pathway: impact on the aging process and age-related diseases.

Authors:  Antero Salminen; Kai Kaarniranta; Anu Kauppinen
Journal:  Inflamm Res       Date:  2021-09-02       Impact factor: 4.575

8.  Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells.

Authors:  Subehan Lallo; Besse Hardianti; Sartini Sartini; Ismail Ismail; Dewi Laela; Yoshihiro Hayakawa
Journal:  Life (Basel)       Date:  2022-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.